Chronic pain patients who show aberrant drug-related behavior often are discontinued from treatment when they are noncompliant with their use of opioids for pain. The purpose of this study was to conduct a randomized trial in patients who were prescribed opioids for noncancer back pain and who showed risk potential for or demonstration of opioid misuse to see if close monitoring and cognitive behavioral substance misuse counseling could increase overall compliance with opioids. Forty-two patients meeting criteria for high-risk for opioid misuse were randomized to either standard control (High-Risk Control; N = 21) or experimental compliance treatment consisting of monthly urine screens, compliance checklists, and individual and group motivational counseling (High-Risk Experimental; N = 21). Twenty patients who met criteria indicating low potential for misuse were recruited to a low-risk control group (Low-Risk Control). Patients were followed for 6 months and completed pre-and post-study questionnaires and monthly electronic diaries. Outcomes consisted of the percent with a positive Drug Misuse Index (DMI), which was a composite score of self-reported drug misuse (Prescription Drug Use Questionnaire), physician-reported abuse behavior (Addiction Behavior Checklist), and abnormal urine toxicology results. Significant differences were found between groups with 73.7% of the High-Risk Control patients demonstrating positive scores on the DMI compared with 26.3% from the High-Risk Experimental group and 25.0% from the Low-Risk Controls (p < 0.05). The results of this study demonstrate support for the benefits of a brief behavioral intervention in the management of opioid compliance among chronic back pain patient at high-risk for prescription opioid misuse. Ó
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Introduction
There has been a growing use of opioids for the treatment of chronic pain, primarily from providers who prescribe them for chronic noncancer pain [24] . It is also estimated that between 3% and 16% of the general population has an addiction disorder [18, 25, 31, 34] , and increasing notice has been given to the abuse of prescription opioid medication [24, 32] . Studies also indicate that chronic pain is two to six times greater among patients with a history of substance abuse [20, 22, 35, 41] . Some pain centers, specialty clinics, or primary care practices in which opioids are prescribed for pain are overwhelmed with these challenging patients, and many physicians prescribing pain medication have little training in the assessment and treatment of aberrant medication-related behavior or opioid addiction [44] . Often these physicians prescribe opioids for patients with chronic pain without any assessment of the level of risk for medication abuse [3] . Such an assessment aids the physician in identifying which patients are likely to develop problems, and who can then employ prophylactic measures to improve opioid therapy compliance [5] .
While substance misuse is prominent in the chronic pain population there is also a greater potential for inadequate treatment of pain for patients with a history of substance misuse due, in part, to a reluctance of some physicians to address the risks of substance misuse in the context of prescribing opioids [22, 29] . Chronic pain patients who show aberrant drug-related behavior often are tapered off opioids and discharged from clinics when they are noncompliant with their use of opioids. Unfortunately, there are few resources for those patients who have chronic pain and a history of prescription opioid misuse.
The Institute of Medicine has directed that persons with chronic pain should be treated in pain programs and opioid use disorders without pain should be treated in addiction treatment centers; however, no allowances are made for those with comorbid disorders of pain and substance abuse [27] . Approximately 40% of chronic pain patients have a co-existing, or comorbid, affective dis- 
